Published in Lab Pract on January 01, 1968
Treatment of Behcet's syndrome with phenformin and ethyloestrenol. Lancet (1969) 2.28
Effect of onions on blood fibrinolytic activity. Br Med J (1968) 1.54
Estimation of euglobulin lysis time using a time-saving recorder. Lab Pract (1969) 1.48
Role of the kidney in fibrinolytic activity of blood. Lancet (1968) 1.46
The role of the lung in blood fibrinolysis. Clin Sci (1969) 1.45
Effect of strenuous and graded exercise on fibrinolytic activity. Lancet (1967) 1.21
Fibrinolysis in pre-eclamptic toxaemia of pregnancy. Br Med J (1969) 1.18
Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran. Br J Dermatol (1969) 1.17
Phenindione sensitivity complicating anticoagulant therapy. J Indian Med Assoc (1966) 1.10
A comparative study of blood fibrinolytic activity in normal women, pregnant women and women on oral contraceptives. J Obstet Gynaecol Br Commonw (1970) 0.97
Phenformin and stanozolol in blood fibrinolytic activity. Br Med J (1970) 0.97
Fasting and non-fasting fibrinolytic activity. Lab Pract (1967) 0.95
Fibrinolytic activity in the blood of 99 healthy young British, African and Asian subjects. Lab Pract (1968) 0.92
Fibrinolytic activity in the blood of Nigerian students after four years' residence in the United Kingdom. Lab Pract (1967) 0.90
A study of possible causes of increased fibrinolytic activity during exercise. Thromb Diath Haemorrh (1969) 0.89
The association between cutaneous vasculitis and decreased blood fibrinolytic activity. Br J Dermatol (1971) 0.89
Fibrinolytic activity of venous blood of patients with multiple sclerosis. Neurology (1969) 0.85
Study of proteins and fibrinolysis in patients with glomerulonephritis. Br Med J (1970) 0.85
Increased fibrinolytic activity in venous blood of hemiplegic limbs. Br Med J (1967) 0.84
Recent trends in antifibrinolytic therapy. Br J Clin Pract (1967) 0.84
Recent trends in fibrinolytic therapy. Br J Clin Pract (1966) 0.84
A study of the possible effects of drugs on fibrinolytic activity in vitro. Lab Pract (1967) 0.84
Muscles as a possible source of plasminogen activators to the circulation. J Assoc Physicians India (1969) 0.84
Comparison of fibrinolytic activity in hepatic and systemic venous blood. J Atheroscler Res (1968) 0.84
The lymphatic system as contributor of plasminogen activator to the blood. Angiologica (1970) 0.81
Syncopal attacks in hypothyroid state. J Indian Med Assoc (1967) 0.81
Pulmonary artery thrombosis and the nephrotic syndrome. Br Med J (1967) 0.81
The uterus as contributor of plasminogen activator to the blood. J Obstet Gynaecol Br Commonw (1970) 0.81
The brain as contributor of plasminogen activator to the blood. Clin Sci (1970) 0.80
Side-effects of phenindione. Br Med J (1968) 0.77
Fibrinolysis in renal disease. Br Med J (1969) 0.77
Aspirin and blood fibrinolysis. Lancet (1970) 0.76
Proteins and fibrinolysis in recipients of renal allografts. J Clin Pathol (1971) 0.75
Onions and blood fibrinolysis. Br Med J (1970) 0.75
Fresh onions and blood fibrinolysis. Br Med J (1969) 0.75
Myocardium as contributor of plasminogen activator to blood. Br Heart J (1971) 0.75
Fibrin degradation products and menstruation. Br Med J (1970) 0.75
Metformin and stanozolol in blood fibrinolytic activity. Br Med J (1971) 0.75
Thrombolytic therapy in coronary thrombosis. J Clin Pathol (1969) 0.75
Fibrinolytic activity in pregnancy. Br Med J (1970) 0.75
Fibrinolytic activity and oral contraception. Br Med J (1970) 0.75
Letter: Source of plasminogen activator. Lancet (1974) 0.75
Medicine in the Soviet Union. J Assoc Physicians India (1980) 0.75
Increased blood-urea during phenformin therapy. Lancet (1970) 0.75
Effect of carbon dioxide inhalation on blood fibrinolytic activity. Lab Pract (1969) 0.75
Venous stasis and fibrinolysis. Lancet (1967) 0.75
A syndrome of cutaneous vasculitis associated with decreased fibrinolytic activity. J Assoc Physicians India (1969) 0.75
A comparison of blood fibrinolytic activity in children and adults. J Assoc Physicians India (1971) 0.75
A study of fibrinolytic acitivity in subjects with different diseases. Lab Pract (1969) 0.75
Fibrinolysis in children with congenital heart-disease. Lancet (1969) 0.75
Blood fibrinolytic activity and thermometry in patients with collagen vascular disease and response to treatment. Biorheology (1970) 0.75
Venous stasis and fibrinolysis. Lancet (1968) 0.75
The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction). Acta Univ Carol Med Monogr (1972) 0.75
Fibrinolytic activity of shunt arterial blood in patients on regular dialysis treatment. Angiologica (1970) 0.75
A study of patients with atherosclerosis and renal disease with respect to lipoprotein types, fibrinolysis, and carbohydrate tolerance. Q J Med (1972) 0.75
Phenformin and ethyloestrenol for Raynaud's disease. Lancet (1969) 0.75
Diurnal variations of fibrinolytic activity and plasma-11-hydroxycorticosteroid levels. Lancet (1967) 0.75
Hyperfibrinogenemia in patients of diabetes mellitus in relation to glycemic control and urinary albumin excretion rate. J Assoc Physicians India (2002) 0.75
Fibrinolytic activity in venous blood of patients with muscular dystrophy. Neurology (1971) 0.75
Preliminary report of beneficial effect of phenformin in combination with ethyloestrenol in treatment of cutaneous vasculitis and Behçet's syndrome. Postgrad Med J (1969) 0.75
Effect of carbon monoxide inhalation on blood fibrinolytic activity. Lab Pract (1970) 0.75
Comparison between blood fibrinolytic activity in the legs and arms and its possible role in phlebothrombosis. Angiologica (1971) 0.75
Venous stasis and fibrinolysis. Lab Pract (1969) 0.75
The muscle as a possible source of plasminogen activator to the blood and their therapeutic implication in the prevention of deep vein thrombosis. Acta Univ Carol Med Monogr (1972) 0.75
Fibrinolytic activity in coronary artery disease and myocardial infarction, and the role of fibrinolytic therapy in coronary thrombosis. Lab Pract (1968) 0.75
A study of the possible correlation of euglobulin lysis time and dilute blood clot lysis time in the determination of fibrinolytic activity. Lab Pract (1968) 0.75
Blood fibrinolytic activity in skin diseases. Angiologica (1970) 0.75
Blood fibrinolytic activity in young Britons, Africans and Asians in relation to their 'weight-for-height' standard. Angiologica (1970) 0.75
The role of the liver in fibrinolysis. A study of hepatic vein blood. J Indian Med Assoc (1967) 0.75
Enhanced blood fibrinolytic activity after direct-current cardioversion. Lab Pract (1970) 0.75
The heart as contributor of plasminogen activator to the blood. J Assoc Physicians India (1970) 0.75